A Safety and Efficacy Study of Intranasal GSK2245035 in Adults With Allergic Asthma
Condition: Asthma Interventions: Drug: GSK2245035; Drug: Placebo; Drug: FP-DPI; Drug: Albuterol/Salbutamol; Other: eDairy; Other: ACQ-6 Sponsor: GlaxoSmithKline Withdrawn (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2018 Category: Research Source Type: clinical trials